Karuna Therapeutics, Inc.
SEC CIK 1771917 · KRTX · last insider filing 2024-03-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Jonas Jeffrey M | Director | filed 2019 - 2024 |
| Coughlin Christopher J | Director | filed 2020 - 2024 |
| Paul Steven M | Director · President & CEO | filed 2019 - 2024 |
| Healy James | Director | filed 2019 - 2024 |
| Meury William | Director · President and CEO | filed 2023 - 2024 |
| Olson Laurie J | Director | filed 2020 - 2024 |
| Pande Atul | Director | filed 2019 - 2024 |
| Wheadon David E. | Director | filed 2020 - 2024 |
| Torres Denice | Director | filed 2020 - 2024 |
| Preston Heather | Director | filed 2019 - 2021 |
| Nelsen Robert | Director | filed 2019 - 2021 |
| Harrigan Edmund | Director | filed 2019 - 2020 |
| Chowrira Bharat M | Director | filed 2019 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Brannan Stephen K. | Chief Medical Officer | filed 2019 - 2024 |
| Miller Andrew Craig | President of R&D | filed 2019 - 2024 |
| Kane William P Jr | Chief Commercial Officer | filed 2023 - 2024 |
| Brown Jason Parker | Chief Financial Officer | filed 2023 - 2024 |
| Ignelzi Troy A. | Chief Financial Officer | filed 2019 - 2023 |
| Lykins Charmaine | Chief Commercial Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.